Pharmaceuticals, Biotechnology and Life Sciences
When her father’s lung cancer worsened, Yin Min, a 51-year-old financial broker from Shanghai, faced a choice: pay nearly $3,000 a month for an approved drug or pay a fraction of the price for a generic drug not approved for use in China.
Premaitha has announced the conditional acquisition of the entire issued share capital of Yourgene.
Japan said on Tuesday it will step up the pace and expand the scope of drug price reviews, one of the most aggressive measures it is taking to rein in ballooning healthcare costs for a rapidly ageing nation.
Bangladesh-based drugmaker Beximco has received approval for its Bristol-Myers Squibb’s (BMS) generic equivalent Glucophage XR tablets, Metformin from the US…
MDxHealth has signed a distribution agreement with AceCGT Life Science Limited for their SelectMDx for Prostate Cancer assay in Hong Kong…
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Strides and Mylan have agree to settle Regulatory and General Claims on Agila transaction.
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine